MSB 0.39% $1.29 mesoblast limited

MSB Trading - 2020, page-16698

  1. 71 Posts.
    lightbulb Created with Sketch. 20
    I don't really understand why anybody would invest in CYP, they have clearly lost the race to Mesoblast hands down.

    I believe that stem cell technology will be the future of medicine and Mesoblast will have a major piece of that action, that is why I have a significant holding in MSB.

    If you really want to diversify in the Stem Cell arena take a look at Reneuron (RENE on AIM). Loaded exosome technology as a delivery system across the blood brain barrier. They are inking JVs with US Biopharma and have a market cap of just 42 million GBP.

    I own shares in RENE but a much larger position in MSB.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.29
Change
0.005(0.39%)
Mkt cap ! $1.467B
Open High Low Value Volume
$1.29 $1.31 $1.27 $1.653M 1.285M

Buyers (Bids)

No. Vol. Price($)
2 16781 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.29 9777 1
View Market Depth
Last trade - 16.10pm 05/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.